AI’s endless adaptability forces us to rethink creativity and partner with tech in the age of digital alchemy.

Jan. 15, 2025 — While most known types of DNA damage are fixed by our cells' in-house DNA repair mechanisms, some forms of DNA damage evade repair and can persist for many years, new research shows.

Jan. 23, 2025 — Researchers have uncovered which genes on the Y chromosome regulate the development of sperm and impact fertility in male mice. This research could help us understand why some ...

Tiffany earned her PhD in Genetics from North Carolina State University, where she explored the effect of genetic background on the ability to derive induced pluripotent stem cells. She completed her ...

Stem cells hold the secret to regenerating tissue and maintaining youthful features. Yet, certain cells, such as melanocyte ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

eLife is a non-profit organisation inspired by research funders and led by scientists. Our mission is to help scientists accelerate discovery by operating a platform for research communication that ...

Patrick Holland has been a phone reviewer for CNET since 2016. He is a former theater director who occasionally makes short films. Patrick has an eye for photography and a passion for everything ...

Cell biology is the discipline of biological sciences that studies the structure, physiology, growth, reproduction and death of cells. Research in cell biology uses microscopic and molecular tools ...

2-Year U.S. Treasury Note Continuous Contract $102.773 0.020 0.02% 5-Year U.S. Treasury Note Continuous Contract $106.211 0.070 0.07% 10-Year U.S. Treasury Note Continuous Contract $108.594 0.125 ...

DNA sequencing is any chemical ... base m6A detection and uncovering regulatory mechanisms in hypoxic cancer cells. The paper describes a Genome in a Bottle benchmark for the X and Y chromosomes ...

Rigel Pharmaceuticals, Inc.  today announced the first patient has been enrolled in a Phase 1 study evaluating the safety and tolerability of escalating doses of fostamatinib, the company's oral ...